Market Tracker

04/16 2:58pm ET
130.87
Real-Time Quote
 +3.07 / +2.40%
Today’s Change
81.33
Today|||52-Week Range
132.04
+17.82%
Year-to-Date

Today’s Trading

Previous close127.80
Today’s open129.74
Day’s range128.69 - 131.05
Volume4,685,602
Average volume (3 months)2,865,808
Market cap$34.9B
Dividend yield0.15%
Data as of 2:43pm ET, 04/16/2014

Growth & Valuation

Earnings growth (last year)+18.75%
Earnings growth (this year)+14.64%
Earnings growth (next 5 years)+14.15%
Revenue growth (last year)+8.37%
P/E ratio31.2
Price/Sales5.24
Price/Book5.37

Competitors

 Today’s
change
Today’s
% change
ACTActavis PLC+4.25+2.19%
SHPGShire PLC+1.64+1.14%
VRXValeant Pharmaceutic...+0.43+0.36%
ALXNAlexion Pharmaceutic...+1.51+1.04%
Data as of 2:58pm ET, 04/16/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)$1.13
Annual revenue (last year)$6.3B
Annual profit (last year)$1.3B
Net profit margin20.17%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David E. I. Pyott
Executive VP-Europe, Africa &
Middle East Region
Douglas S. Ingram
Corporate headquarters
Irvine, California

Forecasts